Interní Med. 2013; 15(6-7): 201-204

Clostridium difficile infection - a still growing risk

prof.MUDr.Petr Husa, CSc.1, prof.MUDr.Jiří Beneš, CSc.2, MUDr.Otakar Nyč, Ph.D.3
1 Klinika infekčních chorob LF MU a FN Brno, Brno
2 Klinika infekčních nemocí 3. LF UK a Nemocnice na Bulovce, Praha
3 Ústav lékařské mikrobiologie 2. LF UK a FN Motol, Praha

Clostridium difficile is the main cause of nosocomial diarrhea in industrialized countries. Clostridium difficile infection (CDI) is a potentially

fatal illness with an increasing incidence worldwide. Despite intensive ongoing research into CDI treatment, management of CDI still

poses serious problems, such as high probability of recurrence and refractoriness to treatment.

Keywords: Clostridium difficile infection (CDI), vancomycin, metronidazole, fidaxomicin

Published: July 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husa P, Beneš J, Nyč O. Clostridium difficile infection - a still growing risk. Interní Med. 2013;15(6-7):201-204.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Savage DC. The microbial flora in the gastrointestinal tract. Prog Clin Biol Res 1981; 77: 893-908.
    2. Cartman ST, Heap JT, Kuehne SA, et al.. The emergence of 'hypervirulence' in Clostridium difficile. Int J Med Microbiol. 2010; 300(6): 387-395. Go to original source... Go to PubMed...
    3. Bishop KD, Castillo JJ. Risk factors associated with Clostridium difficile infection in adult oncology patients with a history of recent hospitalization for febrile neutropenia. Leuk Lymphoma. 2012; 53(8): 1617-1619. Go to original source... Go to PubMed...
    4. Státní zdravotní ústav, databáze Infekce v ČR - EPIDAT, dostupné na www.szu.cz.
    5. Vojtilová L, Freibergerová M, Juránková J, Husa P, Polák P, Kocourková H. Analýza souboru pacientů s onemocněním vyvolaným toxinem Clostridium difficile hospitalizovaných na Klinice infekčních chorob v Brně v letech 2007-2010. Klin mikrobiol inf lék 2011; 17(6): 208-213.
    6. Vojtilová L, Pýchová M, Freibergerová M, Juránková J, Bortlíček Z, Husa P. Rizikové faktory rekurentního a těžkého průběhu kolitidy vyvolané infekcí Clostridium difficile. Vnitř Lék 2013; 59(1): 23-30. Go to PubMed...
    7. Beneš J, Husa P, Nyč O. Doporučený postup diagnostiky a léčby kolitidy vyvolané Clostridium difficile. Klin mikrobiol inf lék 2012; 18(5): 160-167.
    8. Nyč O, Pituch H, Matějková J, et al. Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet 2011; 377(9775): 1407. Go to original source... Go to PubMed...
    9. Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Inf 2009; 15: 1067-1079. Go to PubMed...
    10. Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364: 422-431. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.